Abstract B182: Molecular basis for clinical development of the novel CDK2/9 inhibitor CYC065 in oncology

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Abstract B182: Molecular basis for clinical development of the novel CDK2/9 inhibitor CYC065 in oncology
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 12 Supplement 2, Pages B182-B182
Publisher
American Association for Cancer Research (AACR)
Online
2016-05-20
DOI
10.1158/1535-7163.targ-15-b182

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.